Document Detail


Immunization with Multiple Vaccine Modalities Induce Strong HIV-Specific Cellular and Humoral Immune Responses.
MedLine Citation:
PMID:  23035853     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Abstract Heterologous priming and boosting with antigens expressed by DNA, viral vectors, or as proteins, are experimental strategies to induce strong immune responses against infectious diseases and cancer. In a preclinical study we compared the ability of recombinant modified vaccinia Ankara encoding HIV antigens (MVA-CMDR), and/or recombinant gp140C (rgp140C), to boost responses induced by a multigene/multisubtype HIV DNA vaccine delivered by electroporation (EP). Homologous DNA immunizations augmented by EP stimulated strong cellular immune responses. Still stronger cellular immune responses were observed after DNA priming and MVA-CMDR boosting, which was superior to all other immunization schedules tested in terms of antigen-specific IFN-γ, IL-2, and bifunctional IFN-γ and IL-2 responses. For HIV Env-specific antibody responses, mice receiving repeated rgp140C immunizations, and mice boosted with rgp140C, elicited the highest binding titers and the highest numbers of antibody-secreting B cells. When considering both cellular and humoral immune responses, a combination of DNA, MVA-CMDR, and rgp140C immunizations induced the overall most potent immune responses and the highest avidity of HIV Env-specific antibodies. These data emphasize the importance of including multiple vaccine modalities that can stimulate both T and B cells, and thus elicit strong and balanced immune responses. The present HIV vaccine combination holds promise for further evaluation in clinical trials.
Authors:
David Hallengärd; Steven E Applequist; Sanna Nyström; Anna-Karin Maltais; Mary Marovich; Bernard Moss; Patricia Earl; Kopek Nihlmark; Britta Wahren; Andreas Bråve
Related Documents :
24312123 - Trophoblasts, invasion, and microrna.
23403163 - Combination of a novel hdac inhibitor obp-801/ym753 and a pi3k inhibitor ly294002 syner...
11789673 - Effects of sevoflurane general anesthesia: immunological studies in mice.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Viral immunology     Volume:  25     ISSN:  1557-8976     ISO Abbreviation:  Viral Immunol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8801552     Medline TA:  Viral Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  423-32     Citation Subset:  IM    
Affiliation:
1 Department of Microbiology, Tumor and Cell Biology, Karolinska Institute , Stockholm, Sweden .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chemokine binding protein vCCI attenuates vaccinia virus without affecting the cellular response eli...
Next Document:  Subcutaneous Mastectomy in Female-to-Male Transsexuals: A Retrospective Cohort-Analysis of 202 Patie...